ELIZABETH PERKINS: Open Payments
NPI 1699409383 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 21 payments from 7 companies in 2025. Trend: 2023 $165 · 2024 $1,874 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $183 |
| Incyte Corporation | 1 | $125 |
| Organon LLC | 4 | $80 |
| Arcutis Biotherapeutics, Inc. | 4 | $74 |
| Galderma Laboratories, L.P. | 2 | $68 |
| Lilly USA, LLC | 2 | $62 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: SKYRIZI, Opzelura, VTAMA, Zoryve, NEMLUVIO, TALTZ, EBGLYSS, COSENTYX.
Industry payments across CA — which companies pay providers there.
